Pharma channel feed

Un­ap­proved us­es of ap­proved drugs: FDA lays out phar­ma con­sid­er­a­tions for in­form­ing providers

Last year
FDA+

From Ap­ple to Lil­ly: Drug­mak­er's chief dig­i­tal of­fi­cer talks AI ex­per­i­ments and the GLP-1 cus­tomer ex­pe­ri­ence

Last year
Health Tech

Roivant CEO urges pa­tience on fu­ture af­ter $7B+ sale to Roche

Last year
Deals

As­traZeneca, Dai­ichi Sankyo still need key over­all sur­vival re­sults on TROP2 ADC in breast, lung can­cer: #ES­MO23

Last year
R&D

In­di­v­ior agrees to pay out $385M to end years­long Sub­ox­one lit­i­ga­tion and ac­cu­sa­tions it pre­vent­ed gener­ic com­pe­ti­tion

Last year
Law

Mer­ck ax­es two of nine AD­Cs in pact with Kelun-Biotech

Last year
Deals
China

Ear­ly da­ta on Dai­ichi Sankyo’s Mer­ck-part­nered ADC; As­traZeneca’s Da­to-Dxd com­bo; more from Seagen: #ES­MO23 roundup

Last year
R&D

Roivant flips ul­cer­a­tive col­i­tis drug to Roche for $7.1B, less than a year af­ter get­ting the drug from Pfiz­er

Last year
Deals

Roche de­tails Ale­cen­sa da­ta that may shift the drug to post-surgery ALK-pos­i­tive lung can­cer: #ES­MO23

Last year
R&D

Pad­cev-Keytru­da sets new stan­dard in blad­der can­cer as Seagen and Astel­las move to­ward full ap­proval: #ES­MO23

Last year
R&D

Eli Lil­ly re­veals two-year da­ta for ex­per­i­men­tal eczema treat­ment af­ter FDA road­block

Last year
R&D
FDA+

A first for the Eu­ro­pean Com­mis­sion: Five phar­ma com­pa­nies fined $14M for API price fix­ing

Last year

Pfiz­er wins first US ap­proval for pen­tava­lent meningo­coc­cal vac­cine 

Last year
FDA+

RWD and RWE are not the same: FDA lead­ers dis­pel com­mon mis­con­cep­tions in new pa­per

Last year
FDA+

Eli Lil­ly cracks down on im­porters and dis­trib­u­tors of com­pound­ed Moun­jaro

Last year

Bris­tol My­ers un­corks pos­i­tive PhI­II read­out for sub­cu­ta­neous Op­di­vo

Last year
R&D

Risk-ben­e­fit de­ter­mi­na­tions: FDA fi­nal­izes long-await­ed guid­ance for drug­mak­ers

Last year
FDA+

Eu­ro­pean court rules Te­va, Cephalon must pay $60M fine for re­verse pay­ment scheme af­ter failed ap­peal

Last year
Law

PTC to sell roy­al­ties on block­buster SMA drug Evrys­di for up to $1.5B

Last year
Deals

Mer­ck slams 'dra­con­ian penalties' en­forced un­der IRA in new court fil­ing

Last year

Roche makes four pipeline changes on back of tri­al fail­ures, but sees path ahead for three ther­a­pies

Last year

Pfiz­er sets Paxlovid price at $1,390 for five-day course

Last year
Coronavirus

Emer­gent re­cruits NFL Hall of Famer for Nar­can opi­oid over­dose cam­paign

Last year
Marketing

Pfiz­er agrees to $2M set­tle­ment deal over gen­der dis­crim­i­na­tion al­le­ga­tions

Last year
First page Previous page 9596979899100101 Next page Last page
A service from the Financial Times